BridgeBio to stop development of therapy for genetic disorder-March 2024-www.financetom.com

BridgeBio to stop development of therapy for genetic disorder

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BridgeBio to stop development of therapy for genetic disorder

Sep 11, 2024 4:08 AM

Sept 10 (Reuters) - BridgeBio Pharma ( BBIO ) said on

Tuesday it will stop development of its experimental therapy for

a genetic disease that affects the adrenaline-producing gland.

The drugmaker said the results of its early-to-mid stage

study testing the therapy did not meet the threshold to warrant

additional capital investment.

(Reporting by Puyaan Singh; Editing by Shinjini Ganguli)

Previous page： Hollysys Automation Merger With Ascendent Capital Cleared by Chinese Authorities Next page： Why Ocean Power Shares Are Gaining Today

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Hollysys Automation Merger With Ascendent Capital Cleared by Chinese Authorities

Jul 2, 2024

10:51 AM EDT, 07/02/2024 (MT Newswires) -- Hollysys Automation Technologies ( HOLI ) said Tuesday that a buyer controlled by Ascendent Capital Partners has received all the Chinese regulatory approvals needed to complete their merger transaction. The transaction will close upon the satisfaction or waiver of all closing conditions under the companies' agreement and Hollysys said its common shares will...

Why Ocean Power Shares Are Gaining Today

Jul 2, 2024

Ocean Power Technologies, Inc. ( OPTT ) shares are trading higher after the company announced it partnered with Unique Group for autonomous vehicle services in the Middle East. Unique has more than 600 employees and 20 operational bases around the world. The companies plan to deploy Ocean Power Technologies’ existing WAM-V Unmanned Surface Vehicles in the UAE and other countries...

Arthur J. Gallagher Buys NetClaim

Jul 2, 2024

10:48 AM EDT, 07/02/2024 (MT Newswires) -- Arthur J. Gallagher ( AJG ) said Tuesday that its claims and risk management solutions subsidiary, Gallagher Bassett, has bought NetClaim from NAVEX. Financial details of the acquisition were not disclosed. NetClaim will be integrated into Gallagher Bassett's Incident Management team, the company said. Price: 260.02, Change: +0.79, Percent Change: +0.31 ...

Arq Added to Russell 3000, Russell 2000 Indexes

Jul 2, 2024

10:49 AM EDT, 07/02/2024 (MT Newswires) -- Arq (ARQ) said Tuesday it been added to the Russell 3000, and Russell 2000 indexes, effective Monday. Shares of the environmental technology company were down 0.7% in recent trading. Price: 5.62, Change: -0.04, Percent Change: -0.71 ...